The maker of Taytulla birth-control treatment issued a nationwide recall in the United States on Tuesday over concerns that misplaced capsules in pill packs could cause unintended pregnancies.
A physician reported that four placebo capsules were packaged in the wrong order where active capsules should have been, drugmaker Allergan said in a statement.
The physician sample pack should have 24 pink capsules with hormones followed by four maroon capsules without hormones, Allergan said. Instead, the faulty pack had four maroon placebos at the start of the treatment.
"As a result of this packaging error, oral contraceptive capsules that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy," the statement said.
"The reversing of the order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the capsules out of order."
Allergan said it is arranging for return of all sample pack products with the lot #5620706 Exp. May 2019. The drug maker urged patients to consult their physicians if they think they are affected by the recall.
- Drugmaker recalls birth control pills packaged in wrong order
- Male birth control pill one step closer to reality, researchers say
- Bayer paid doctors for Essure birth control
- Discount drugmaker Teva is cutting 14,000 jobs
- Database details drugmakers' contributions to Congress
- Lawmakers to introduce "12 Months of Birth Control" legislation
- FDA tightens restrictions on Essure birth control device
- This local health initiative has expanded birth control access
- Bayer to stop selling Essure birth control device in US
- Combined birth control may reduce ovarian cancer risk